In reply to “Selpercatinib controls central nervous system disease in patients with RET fusion-positive NSCLC” Correspondence

  

Authors:	Murciano-Goroff, Y. R.; Lin, S. T.; Wilhelm, C.; Iasonos, A.; Drilon, A.
Title:	In reply to “Selpercatinib controls central nervous system disease in patients with RET fusion-positive NSCLC”
Journal Title:	Journal of Thoracic Oncology
Volume:	18
Issue:	5
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2023-05-01
Start Page:	e52
End Page:	e53
Language:	English
DOI:	10.1016/j.jtho.2023.02.011
PUBMED:	37087124
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85152932436&doi=10.1016%2fj.jtho.2023.02.011&partnerID=40&md5=af96b3bd6a9bb8fbe97b876cf7a7b41d
Notes:	Letter -- Export Date: 1 May 2023 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/205629